Delivery Order SPE2DB22D2206-SPE2DB24FHV72
Award Date
6/20/24
Potential Completion Date
7/12/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $14,627.04, is for the delivery of 4,565,483,195 units of the biopharmaceutical product Rituxan Hycela 1,400 mg-23,400 11.7 ml. This contract supports the federal government's medical supply needs, providing critical care medications to military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,535.52 firm fixed-price delivery order is for the supply of 500mg/50mL vials of the drug Rituximab, which is used to treat certain types of cancer and autoimmune disorders. The contract has an ultimate completion date of September 5, 2024 and was awarded on September 4, 2024. It is not designated as a set-aside contract....
This is a delivery order contract awarded by the Office of the Chief Operating Officer, a civilian federal agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $99,140.57 and is for the delivery of RITUXAN 500MG VL 50ML medical supplies. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $8,083.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,275.45, is a Firm Fixed Price Delivery Order for the supply of 4564660868 RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has a completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $10,028.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) against the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the procurement of 4565255148 - RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government's Defense Logistics Agency (DLA) Troop Support Medical program. The contract has a ceiling value of $13,145.74 and a performance period through August 27, 2024. As a delivery order contract, it allows the government to efficiently procure essential medical commodities, including specialty...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract provides for the delivery of the pharmaceutical product Ruxience 500 mg/50 ml vial with an ultimate completion date of October 6, 2023. The Firm Fixed Price award has a ceiling value of $18,937.23. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a variety of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $7,978.05, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen supplies a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,841.49, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to $999,999,999.00 through December 31, 2025, serves as the primary...